NCT04337424View on ClinicalTrials.gov

Evaluation of Quickly Diagnostic Saliva Tests for SARS-CoV-2

CompletedOBSERVATIONAL
Enrollment

627

Participants

Timeline

Start Date

April 13, 2020

Primary Completion Date

October 7, 2020

Study Completion Date

October 7, 2020

Conditions
SARS-CoV-2
Interventions
DIAGNOSTIC_TEST

Sampling salivary

Collection of 1 to 2 ml of saliva

Trial Locations (1)

34295

UCH Montpellier, Montpellier

All Listed Sponsors
collaborator

societe SkillCell - 97198 Jarry

UNKNOWN

collaborator

CNRS Alcediag UMR9005 - societe Sys2Diag - 34184 Montpellier

UNKNOWN

lead

University Hospital, Montpellier

OTHER

NCT04337424 - Evaluation of Quickly Diagnostic Saliva Tests for SARS-CoV-2 | Biotech Hunter | Biotech Hunter